FDA product code LFX: Enzyme Linked Immunoabsorbent Assay, Rubella
LFX is the FDA product code for enzyme linked immunoabsorbent assay, rubella. It is a Class II device, regulated under 21 CFR 866.3510 and reviewed by the Microbiology panel. FDA has cleared 94 510(k) submissions under LFX, 2 in the last five years, from 50 different applicants. The average 510(k) review took 172 days (median 136); 263 days on average over the last three years. FDA has posted 15 recalls for LFX devices.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device class | Class II |
| Regulation | 21 CFR 866.3510 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for LFX
| Year | Clearances | Avg. review days |
|---|---|---|
| 2025 | 2 | 263 |
Compare with all 510(k) review times · Search every LFX clearance
Top LFX applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Abbott Laboratories | 8 | 2025-06-20 |
| Diamedix Corp. | 5 | 2011-01-21 |
| Zeus Scientific, Inc. | 5 | 2007-03-21 |
| Gull Laboratories, Inc. | 5 | 1995-08-04 |
| Ortho Diagnostic Systems, Inc. | 5 | 1990-12-04 |
45 more applicants have LFX clearances. See the full list in Caduvo.
Most recent LFX clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K250588 | Beckman Coulter, Inc. | Access Rubella IgG | 2025-11-17 | 263 |
| K243168 | Abbott Laboratories | Alinity i Rubella IgG | 2025-06-20 | 263 |
| K122397 | DiaSorin, Inc. | LIAISON RUBELLA IGM, LIAISON CONTROL RUBELLA IGM | 2012-09-06 | 30 |
| K093101 | Diamedix Corp. | MAGO 4S | 2011-01-21 | 477 |
| K092587 | Bio-Rad Laboratories | BIOPLEX 2200 RUBELLA & CMV IGM KIT ON THE BIOPLEX 2200 MULTI ANALYTE DETECTION SYSTEM | 2010-12-03 | 466 |
Recalls for LFX devices
15 product recalls in 12 recall events; 0 initiated in the last five years and 1 still open. Most recent: 2021-09-22.
| Year | Recalls |
|---|---|
| 2021 | 1 |
Frequently asked questions
What is FDA product code LFX?
LFX is the FDA product code for enzyme linked immunoabsorbent assay, rubella. It is a Class II device, regulated under 21 CFR 866.3510 and reviewed by the Microbiology panel.
What device class is LFX?
Class II, regulation 21 CFR 866.3510. Typical premarket route: 510(k).
How long does a 510(k) take for product code LFX?
Across 94 cleared submissions the average was 172 days from receipt to decision (median 136).
Which companies have the most LFX clearances?
Abbott Laboratories (8); Diamedix Corp. (5); Zeus Scientific, Inc. (5); Gull Laboratories, Inc. (5); Ortho Diagnostic Systems, Inc. (5).
Have LFX devices been recalled?
Yes: 15 product recalls across 12 recall events; the most recent began 2021-09-22.
Next steps
- Run an FDA pathway report with predicate devices for product code LFX
- Run a recall and safety report across every LFX manufacturer
- Watch product code LFX for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times